PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS)

Clinical trials for PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS) explained in plain language.

Never miss a new study

Get alerted when new PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS) trials appear

Sign up with your email to follow new studies for PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Major trial aims to crack tough lung infection

Disease control Recruiting now

This study is for people with a hard-to-treat lung infection called MABS. It compares different drug combinations to find which works best to clear the infection while causing the fewest side effects. About 300 adults will take part, and the goal is to improve health and quality …

Matched conditions: PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS)

Phase: PHASE2, PHASE3 • Sponsor: The University of Queensland • Aim: Disease control

Last updated Jun 09, 2026 12:09 UTC

PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS)

Get alerted when new PULMONARY DISEASE DUE TO MYCOBACTERIA (DIAGNOSIS) trials appear

Major trial aims to crack tough lung infection